Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, FLIR Systems, Medtronic, Cirrus Logic and HollySys Automation Technologies

For Immediate Release

Chicago, IL – April 25, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Vertex Pharmaceuticals Inc. (VRTX), FLIR Systems, Inc. (FLIR), Medtronic plc (MDT), Cirrus Logic Inc. (CRUS) and HollySys Automation Technologies, Ltd. (HOLI).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday’s Analyst Blog:

Top Stocks with Earnings Acceleration

As we are in the thick of the first-quarter earnings season, investors should search for stocks that are ready to make a big move. Significant earnings growth generally leads to a jump in share price, but earnings acceleration works even better in boosting the stock price.

Earnings acceleration is basically incrementally growing EPS of a company. In other words, if the rate of a company’s quarter-over-quarter earnings growth increases over a considerable period, it is termed as earnings acceleration.

If you pick a stock just by focusing on the company’s earnings growth then you are paying for something that has already been reflected in the stock price. Earnings acceleration, on the other hand, considers both direction and magnitude of growth rates. This helps you in betting on a stock that is yet to see significant attention of investors, and consequently a solid price increase.

Increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period of time. Sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may at times drag prices down.

Hence, earnings acceleration should be viewed as a key metric for share price outperformance.

Screening Parameters :

Let’s look for stocks for which last two quarter-over-quarter percentage EPS growth rates are more than the growth rates of the previous periods. The projected quarter-over-quarter percentage EPS growth rate is also expected to be higher than the previous periods’ growth rates.

EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1): The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1).

EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2): The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2).

EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3): The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3).

In addition to this, we have added:

Current Price greater than or equal to $5 : This screens out the low priced stocks.

Average 20-day volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

Here are five of the 15 stocks made it through the screen:

Vertex Pharmaceuticals Inc. (VRTX)

FLIR Systems, Inc. (FLIR)

Medtronic plc (MDT)

Cirrus Logic Inc. (CRUS)

HollySys Automation Technologies, Ltd. (HOLI)

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

Want the latest recommendations from Zacks Investment Research? Today, you can download7 Best Stocks for the Next 30 Days. Click to get this free report >>.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today. Find out What is happening in the stock market today on zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
VERTEX PHARM (VRTX): Free Stock Analysis Report
 
FLIR SYSTEMS (FLIR): Free Stock Analysis Report
 
MEDTRONIC (MDT): Free Stock Analysis Report
 
CIRRUS LOGIC (CRUS): Free Stock Analysis Report
 
HOLLYSYS AUTOMT (HOLI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.